Nigel John Brunskill
Impact in
- Nephrology top 0.2%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
- Dialysis and Renal Disease Management
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Nephrology 54
- Chronic Kidney Disease and Diabetes 37
- Renal Diseases and Glomerulopathies 19
- Dialysis and Renal Disease Management 10
-
- COVID-19 Clinical Research Studies 7
- Co-authors
- Claire Elizabeth Hills (6 shared papers)Richard J. Baines (7 shared papers)Rupert Major (16 shared papers)Laura J. Gray (12 shared papers)John Walls (6 shared papers)Ravinder S. Chana (11 shared papers)Gary B. Willars (5 shared papers)Andrew J P Lewington (5 shared papers)
- Journals
- Journal of the American Society of Nephrology (9 papers)Kidney International (9 papers)American Journal of Physiology-Renal Physiology (8 papers)Nephrology Dialysis Transplantation (7 papers)The Lancet (6 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Nigel John Brunskill
154 papers receiving 8.1k citations
Nigel John Brunskill's Hit Papers
Peers
Comparison fields: 5 of 154
- Nephrology 1.9k
- Infectious Diseases 1.6k
- Neurology 1.2k
- Critical Care and Intensive Care Medicine 251
- Endocrinology, Diabetes and Metabolism 667
Countries citing papers authored by Nigel John Brunskill
This map shows the geographic impact of Nigel John Brunskill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel John Brunskill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel John Brunskill more than expected).
Fields of papers citing papers by Nigel John Brunskill
This network shows the impact of papers produced by Nigel John Brunskill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel John Brunskill. The network helps show where Nigel John Brunskill may publish in the future.
Co-authors
The 25 scholars most cited alongside Nigel John Brunskill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 160 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study Hit paper breakdown → | 2021 | 470 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 3 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 4 | Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study Hit paper breakdown → | 2022 | 307 |
| 5 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 6 | Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies Hit paper breakdown → | 2019 | 267 |
| 7 | Conversion of Urine Protein–Creatinine Ratio or Urine Dipstick Protein to Urine Albumin–Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis Hit paper breakdown → | 2020 | 248 |
| 8 | 2018 | 245 | |
| 9 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 10 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 11 | Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes Hit paper breakdown → | 2023 | 200 |
| 12 | 2018 | 192 | |
| 13 | 2018 | 191 | |
| 14 | 2021 | 163 | |
| 15 | 2004 | 137 | |
| 16 | 2002 | 122 | |
| 17 | 2003 | 118 | |
| 18 | 1999 | 115 | |
| 19 | 2020 | 112 | |
| 20 | 2022 | 104 |
About Nigel John Brunskill
Nigel John Brunskill is a scholar working on Nephrology, Infectious Diseases, Molecular Biology, Pediatrics, Perinatology and Child Health and Pathology and Forensic Medicine, having authored 160 papers that have together received 8.4k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (37 papers), Renal Diseases and Glomerulopathies (19 papers), Dialysis and Renal Disease Management (10 papers), Pregnancy and Medication Impact (9 papers), Diabetes and associated disorders (8 papers), COVID-19 Clinical Research Studies (7 papers), Metabolism, Diabetes, and Cancer (7 papers) and Biomedical Research and Pathophysiology (7 papers). The work is most often cited by research in Nephrology (1.9k citations), Infectious Diseases (1.6k citations), Neurology (1.2k citations), Critical Care and Intensive Care Medicine (251 citations) and Endocrinology, Diabetes and Metabolism (667 citations). Nigel John Brunskill has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Claire Elizabeth Hills, Richard J. Baines, Rupert Major, Laura J. Gray, John Walls, Ravinder S. Chana, Gary B. Willars, Andrew J P Lewington, James O. Burton and Peter N Furness. Their work appears in journals such as Journal of the American Society of Nephrology, Kidney International, American Journal of Physiology-Renal Physiology, Nephrology Dialysis Transplantation and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.